Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

GALT stock

Galectin Therapeutics (NASDAQ:GALT) Stock Sees Big Rally: Time to Sell?

Positive news with regards to a major trial can often propel a biotech or pharmaceutical stock to new highs and that is what happened with the Galectin Therapeutics (NASDAQ:GALT) stock on Friday. The company, which is based out of Georgia, saw its stock soar by as much as 25% yesterday after the company announced positive …

Continue reading “Galectin Therapeutics (NASDAQ:GALT) Stock Sees Big Rally: Time to Sell?”

Galectin Therapeutics (NASDAQ:GALT) Stock Rockets: How Far Can It Go?

Those who are monitoring the action in the premarket trading period may have noticed that the Galectin Therapeutics Inc (NASDAQ:GALT) has emerged as an early winner and soared by 50% at the time of writing. This morning the company announced positive top line data with regards to the combination therapy of KEYTRUDA and Belapectin, which …

Continue reading “Galectin Therapeutics (NASDAQ:GALT) Stock Rockets: How Far Can It Go?”

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.